Side-by-side comparison of AI visibility scores, market position, and capabilities
Kenvue-owned (KVUE) dermatologist-recommended skincare brand with Hydro Boost moisturizer; competing with CeraVe and La Roche-Posay for the derm-approved facial care market as TikTok skincare grows.
Neutrogena is a dermatologist-recommended skincare brand offering facial cleansers, moisturizers, sunscreens, acne treatments, and anti-aging products at mass-market price points — known for its signature fragrance-free, hypoallergenic formulations and the iconic Transparent Facial Bar soap. Founded in Los Angeles in 1930, Neutrogena was acquired by Johnson & Johnson (NYSE: JNJ) in 1994 and is part of J&J's consumer health business, which was spun off as Kenvue (NYSE: KVUE) in 2023 alongside Band-Aid, Tylenol, Aveeno, and Listerine.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.